“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Neurofibromatosis (NF) is a genetic disorder that affects the nervous system and can cause tumors to grow on nerves. It is caused by mutations in the genes that regulate cell growth and division. There are three main types of neurofibromatosis:
There is no cure for NF, but treatment can help manage symptoms and complications. Treatment may include surgery to remove tumors, radiation therapy, and medication to manage pain or other symptoms. People with NF may also benefit from genetic counseling and support from healthcare professionals and advocacy organizations.
Neurofibromatosis is caused by genetic defects (mutations) that either are passed on by a parent or occur spontaneously at conception. The specific genes involved depend on the type of neurofibromatosis:
There isn't a cure for neurofibromatosis, but signs and symptoms can be managed. Generally, the sooner someone is under the care of a doctor trained in treating neurofibromatosis, the better the outcome.
If your child has NF1, your doctor is likely to recommend yearly age-appropriate checkups to:
Contact your doctor promptly if you notice any changes in signs or symptoms between visits. Many complications of NF1 can be treated effectively if therapy starts early.
Selumetinib (Koselugo) is a treatment for plexiform neurofibroma in children. Clinical trials of similar drugs are currently ongoing for children and adults.
Your doctor might recommend surgery or other procedures to treat severe symptoms or complications of neurofibromatosis.
Malignant tumors and other cancers associated with neurofibromatosis are treated with standard cancer therapies, such as surgery, chemotherapy and radiation therapy. Early diagnosis and treatment are the most important factors contributing to a good outcome.
Managing pain is an important part of treatment for schwannomatosis. Your doctor might recommend:
Researchers are testing gene therapies for NF1. Potential new treatments could include replacing the NF1 gene to restore the function of neurofibromin.